ePrescribing Market Size, Trends, Analysis, and Outlook By Product (Solutions, Services), By Delivery Mode (Cloud Based, On Premise), By End-User (Hospital, Office-based Physicians, Pharmacy), By Usage Methods (Handheld, Computer Based Devices), By Substa

ePrescribing Market Size, Trends, Analysis, and Outlook By Product (Solutions, Services), By Delivery Mode (Cloud Based, On Premise), By End-User (Hospital, Office-based Physicians, Pharmacy), By Usage Methods (Handheld, Computer Based Devices), By Substances (Controlled Substances, Non-controlled Substances), By Application (Oncology, Sports Medicine, Neurology, Cardiology, Others), by Country, Segment, and Companies, 2024-2032

The global ePrescribing market size is poised to register 18.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ePrescribing market across By Product (Solutions, Services), By Delivery Mode (Cloud Based, On Premise), By End-User (Hospital, Office-based Physicians, Pharmacy), By Usage Methods (Handheld, Computer Based Devices), By Substances (Controlled Substances, Non-controlled Substances), By Application (Oncology, Sports Medicine, Neurology, Cardiology, Others)

The ePrescribing market is driven by the increasing adoption of electronic health record (EHR) systems and digital prescribing platforms, advancements in ePrescribing software and interoperability standards, and the growing emphasis on medication safety and healthcare efficiency. By 2030, the market is expected to witness significant growth, fueled by innovations in electronic prescribing networks, medication management tools, and clinical decision support systems. Further, expanding applications in telemedicine, medication reconciliation, and medication therapy management are anticipated to drive market expansion, enabling prescribers, pharmacists, and patients to streamline medication ordering, reduce medication errors, and improve medication adherence through ePrescribing solutions that offer integration, accessibility, and real-time medication data exchange for safer and more effective prescribing practices in healthcare delivery.

ePrescribing Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The ePrescribing market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of ePrescribing survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the ePrescribing industry.

Key market trends defining the global ePrescribing demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

ePrescribing Market Segmentation- Industry Share, Market Size, and Outlook to 2032

The ePrescribing industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support ePrescribing companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the ePrescribing industry

Leading ePrescribing companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 ePrescribing companies.

ePrescribing Market Study- Strategic Analysis Review

The ePrescribing market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

ePrescribing Market Size Outlook- Historic and Forecast Revenue in Three Cases

The ePrescribing industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2032 in three case scenarios- low case, reference case, and high case scenarios.

ePrescribing Country Analysis and Revenue Outlook to 2032

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2032. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2032.

North America ePrescribing Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong healthcare infrastructure. Leading companies focus on new product launches in the changing environment. The US healthcare expenditure is expected to grow to $4.8 trillion in 2024 (around 3.7% growth in 2024), potentially driving demand for various ePrescribing market segments. Similarly, Strong market demand is encouraging Canadian ePrescribing companies to invest in niche segments. Further, as Mexico continues to strengthen its relations and invest in technological advancements, the Mexico ePrescribing market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe ePrescribing Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European ePrescribing industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of vendors in identifying and leveraging new growth prospects positions the European ePrescribing market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific ePrescribing Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for ePrescribing in Asia Pacific. In particular, China, India, and South East Asian ePrescribing markets present a compelling outlook for 2032, acting as a magnet for both domestic and multinational vendors seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major countries in the APAC region.

Latin America ePrescribing Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa ePrescribing Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East ePrescribing market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for ePrescribing.

ePrescribing Market Company Profiles

The global ePrescribing market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Allscripts Healthcare LLC, Athenahealth Inc, Cerner Corp, Change Healthcare LLC, DrFirst, Epic Systems Corp, McKesson Corp, NextGen Healthcare Inc, Practice Fusion Inc, RXNT (Networking Technology Inc), Surescripts LLC.

Recent ePrescribing Market Developments

The global ePrescribing market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

ePrescribing Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2032 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Product

Solutions

Services

By Delivery Mode

Cloud Based

On Premise

By End-User

Hospital

Office-based Physicians

Pharmacy

By Usage Methods

Handheld

Computer Based Devices

By Substances

Controlled Substances

Non-controlled Substances

By Application

Oncology

Sports Medicine

Neurology

Cardiology

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

Allscripts Healthcare LLC

Athenahealth Inc

Cerner Corp

Change Healthcare LLC

DrFirst

Epic Systems Corp

McKesson Corp

NextGen Healthcare Inc

Practice Fusion Inc

RXNT (Networking Technology Inc)

Surescripts LLC

Formats Available: Excel, PDF, and PPT